Pasithea Therapeutics (KTTA) Accumulated Depreciation (2022 - 2024)
Historic Accumulated Depreciation for Pasithea Therapeutics (KTTA) over the last 3 years, with Q3 2024 value amounting to $37636.0.
- Pasithea Therapeutics' Accumulated Depreciation changed N/A to $37636.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $37636.0, marking a year-over-year change of. This contributed to the annual value of $23488.0 for FY2023, which is 55996.07% up from last year.
- Per Pasithea Therapeutics' latest filing, its Accumulated Depreciation stood at $37636.0 for Q3 2024.
- Pasithea Therapeutics' 5-year Accumulated Depreciation high stood at $37636.0 for Q3 2024, and its period low was $3559.0 during Q4 2022.
- Moreover, its 3-year median value for Accumulated Depreciation was $28205.0 (2024), whereas its average is $25161.6.
- Over the last 5 years, Pasithea Therapeutics' Accumulated Depreciation had its largest YoY gain of 55996.07% in 2023, and its largest YoY loss of 55996.07% in 2023.
- Over the past 3 years, Pasithea Therapeutics' Accumulated Depreciation (Quarter) stood at $3559.0 in 2022, then soared by 559.96% to $23488.0 in 2023, then surged by 60.24% to $37636.0 in 2024.
- Its last three reported values are $37636.0 in Q3 2024, $32920.0 for Q2 2024, and $28205.0 during Q1 2024.